Global Amniotic Membrane Market (2021 to 2028) – by Product Type, Application End-user and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Amniotic Membrane Market, by Product Type, by Application, by End User, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering.

Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids. According to a study published by the National Center for Biotechnology Information (NCBI) in February 2021, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.

Market players are focused on research and development activities to obtain approvals for novel products or techniques associated with amniotic membrane, this could contribute to the growth of the market over the forecast period. For instance, in 2018, MiMedx, an American biomedical company received the status of Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Administration for its product AmnioFix, an amniotic membrane that is designed for use in osteoarthritis treatment.

Market players are focusing on product launches, which is expected to strengthen their position in the global market. For instance, on February, 2020, Integra LifeSciences, an American medical technology company launched AmnioExcel Plus amniotic membrane that helps in wound care.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the amniotic membrane market globally. For instance, in 2017, Organogenesis Holdings Inc., an American regenerative medicine company acquired NuTech Medical, an American biologics company, to expand their company product portfolio and support the development of next generation amniotic membrane products.

Key features of the study:

• This report provides an in-depth analysis of global amniotic membrane market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global amniotic membrane market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global amniotic membrane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the amniotic membrane market

Company Profiles

• Smith & Nephew
• Applied Biologics
• Organogenesis Holdings Inc.
• Osiris Therapeutics, Inc.
• Alliqua BioMedical, Inc.
• Amnio Technology, LLC
• Next Biosciences
• Integra LifeSciences
• MiMedx
• LifeCell International
• Human Regenerative Technologies, LLC
• Amniox Medical, Inc.
• Skye Biologics Inc.
• Wright Medical
• TissueTech
• Katena Products, Inc.
• NuVision Biotherapies
• Surgenex
• Ventris Medical

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Porter’s Analysis
• Industry Trends
• Key Highlights
• Epidemiology
• Reimbursement Scenario of Amniotic Membranes
• Regulatory Scenario
• Product Launch and Approvals
• Acquisition and Collaboration Scenario

4. COVID – 19 Impact Analysis

• COVID-19 Epidemiology
• Impact of COVID-19 on Demand and Supply of Amniotic Membranes
• Impact of COVID-19 on the overall Healthcare Sector

5. Global Amniotic Membrane Market, By Product Type, 2017-2028 (US$ Million)

6. Global Amniotic Membrane Market, By Application, 2017 – 2028 (US$ Million)

7. Global Amniotic Membrane Market, By End User, 2017 – 2028 (US$ Million)

8. Global Amniotic Membrane Market, By Region, 2017 – 2028 (US$ Million)

9. Competitive Landscape

10. Section

For more information about this report visit https://www.researchandmarkets.com/r/e8snj2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900